NEKTAR THERAPEUTICS Annual Net Cash Provided by (Used in) Operating Activities in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nektar Therapeutics quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2023.
- Nektar Therapeutics Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$47.9M, a 7.76% increase year-over-year.
- Nektar Therapeutics annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$193M, a 36.6% increase from 2022.
- Nektar Therapeutics annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$304M, a 26.3% increase from 2021.
- Nektar Therapeutics annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$413M, a 31.7% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)